
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hypercalcemia risk factors
Introduction
Overview
Overview
Common risk factors in the development of hypercalcemia include postmenopausal women, age group 50-60 year, family history of hyperparathyroidism, history of familial syndromes, and renal diseases.
Risk Factors
Risk Factors
Common Risk Factors
Common risk factors in the development of hypercalcemia include:
- Postmenopausal women
- Age group 50-60 years
- Family history of hyperparathyroidism
- History of familial syndromes such as multiple endocrine neoplasia type 1, type 2A or type 4; familial hypocalciuric hypercalcemia, hyperparathyroid-jaw tumor syndrome
Common risk factors in the development of hypercalcemia in chronic renal failure include:[1]
- High serum phosphorus expression levels
- Low serum creatinine expression levels
- Low serum calcium expression levels
- Female gender
- Hypertension
Common risk factors in the development of hypercalcemia post renal transplantation include:[2]
- Elderly individuals
- Longer duration of dialysis
Less Common Risk Factors
Less common risk factors in the development of hypecalcemia include:
Less common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include:[1]
References
References
- ↑ 1.0 1.1 Wei Y, Lin J, Yang F, Li X, Hou Y, Lu R, Shi X, Liu Z, Du Y (2016). “Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease”. Exp Ther Med. 12 (2): 1206–1212. doi:10.3892/etm.2016.3438. PMC 4950648. PMID 27446345.
- ↑ Hamidian Jahromi A, Roozbeh J, Raiss-Jalali GA, Dabaghmanesh A, Jalaeian H, Bahador A, Nikeghbalian S, Salehipour M, Salahi H, Malek-Hosseini A (2009). “Risk factors of post renal transplant hyperparathyroidism”. Saudi J Kidney Dis Transpl. 20 (4): 573–6. PMID 19587496.
- ↑ Szalat, Auryan; Mazeh, Haggi; Freund, Herbert R (2009). “Lithium-associated hyperparathyroidism: report of four cases and review of the literature” (PDF). European Journal of Endocrinology. 160: 317–323.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
